181 related articles for article (PubMed ID: 32598338)
21. [A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION SUCCESSFULLY TREATED WITH SHORT-TERM CAM, AMK, AND IPM/cs FOLLOWED BY LONG-TERM ORAL CAM AND LVFX].
Hashiguchi N; Inoshima N; Inoshima I
Kekkaku; 2015 Jun; 90(6):549-52. PubMed ID: 26489157
[TBL] [Abstract][Full Text] [Related]
22.
Gonzales Zamora JA; Villar Astete A
Acta Clin Belg; 2020 Dec; 75(6):429-433. PubMed ID: 31253072
[No Abstract] [Full Text] [Related]
23. An Intensified Regimen Containing Linezolid Could Improve Treatment Response in
Li H; Tong L; Wang J; Liang Q; Zhang Y; Chu N; Chen X; Duan H
Biomed Res Int; 2019; 2019():8631563. PubMed ID: 31828137
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China.
Wen S; Gao X; Zhao W; Huo F; Jiang G; Dong L; Zhao L; Wang F; Yu X; Huang H
Int J Infect Dis; 2021 Aug; 109():253-260. PubMed ID: 34216736
[TBL] [Abstract][Full Text] [Related]
25. A case of a preschool child with a successful kidney transplant following the long-term administration of antibiotics to treat peritoneal dialysis-related ESI/peritonitis by Mycobacterium abscessus.
Nakano S; Yamamura-Miyazaki N; Michigami T; Yazawa K; Yanagihara I; Yamamoto K
CEN Case Rep; 2022 Nov; 11(4):408-411. PubMed ID: 35179697
[TBL] [Abstract][Full Text] [Related]
26. Mycobacterium chelonae peritonitis in peritoneal dialysis. Literature review.
Kunin M; Knecht A; Holtzman EJ
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1267-71. PubMed ID: 24569948
[TBL] [Abstract][Full Text] [Related]
27. Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections.
Negatu DA; Aragaw WW; Cangialosi J; Dartois V; Dick T
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0165522. PubMed ID: 36920191
[TBL] [Abstract][Full Text] [Related]
28. Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis.
Vera G; Lew SQ
Am J Nephrol; 1999; 19(5):586-9. PubMed ID: 10575188
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
Kidd JM; Abdelraouf K; Nicolau DP
J Antimicrob Chemother; 2019 Apr; 74(4):970-977. PubMed ID: 30561650
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary Mycobacterium abscessus Infection in an 11-Year-Old Child, Successfully Treated with Inhaled/Parenteral Amikacin: A Case Report and Review of Literature.
Deniz M; Ramaslı Gursoy T; Tapısız A; Tezer H; Aslan AT
J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34059924
[TBL] [Abstract][Full Text] [Related]
31. Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity Infections
Joseph WS; Culshaw D; Anuskiewicz S; De Anda C; Prokocimer P
J Am Podiatr Med Assoc; 2017 Jul; 107(4):264-271. PubMed ID: 27533787
[TBL] [Abstract][Full Text] [Related]
32. Successful use of intravenous linezolid in CAPD patient with vancomycin-resistant enterococcal peritonitis.
Yang JW; Kim YS; Choi SO; Han BG
Perit Dial Int; 2011; 31(2):209-10. PubMed ID: 21427253
[No Abstract] [Full Text] [Related]
33. Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.
Parize P; Hamelin A; Veziris N; Morand PC; Guillemain R; Lortholary O; Dupin N
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):101-5. PubMed ID: 25677464
[TBL] [Abstract][Full Text] [Related]
34. Tedizolid: a service evaluation in a large UK teaching hospital.
York JA; Adams K; Cullen L; Delahay J; Ivan M; Lillie PJ; MacLachlan L; Barlow G
Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):397-405. PubMed ID: 32851509
[TBL] [Abstract][Full Text] [Related]
35. A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity
Guo Q; Xu L; Tan F; Zhang Y; Fan J; Wang X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0088921. PubMed ID: 34460305
[TBL] [Abstract][Full Text] [Related]
36. In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid.
Zhang H; Hua W; Lin S; Zhang Y; Chen X; Wang S; Chen J; Zhang W
Infect Drug Resist; 2022; 15():4845-4852. PubMed ID: 36045871
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal dialysis-associated peritonitis caused by Mycobacteroides massiliense: the first case and review of the literature.
Hamada S; Takata T; Kitaura T; Teraoka C; Aono A; Taniguchi S; Mae Y; Isomoto H; Chikumi H; Mitarai S
BMC Nephrol; 2021 Mar; 22(1):90. PubMed ID: 33711948
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report.
Yoshimura R; Kawanishi M; Fujii S; Yamauchi A; Takase K; Yoshikane K; Egawa M; Shiina H; Ito T
BMC Nephrol; 2018 Nov; 19(1):341. PubMed ID: 30497395
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal dialysis fluid concentrations of linezolid in the treatment of vancomycin-resistant Enterococcus faecium peritonitis.
DePestel DD; Peloquin CA; Carver PL
Pharmacotherapy; 2003 Oct; 23(10):1322-6. PubMed ID: 14594349
[TBL] [Abstract][Full Text] [Related]
40. Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.
Choi CW; Cha DR; Kwon YJ; Cho WY; Pyo HJ; Kim HK
Korean J Intern Med; 1993 Jan; 8(1):25-7. PubMed ID: 8268143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
